AdherePredict is a purpose-built platform that helps pharmaceutical companies increase medication adherence, reduce costs, and improve health outcomes - by combining predictive analytics with NHS-aligned patient support.

AdherePredict is an intelligent adherence-prediction platform designed to identify, predict, and support patients at risk of non-adherence to treatment. Using patient-level data and real-time behavioural insights, it enables pharmaceutical companies to develop targeted interventions that keep patients on therapy - and improve long-term outcomes.
AdherePredict is an in-road to truly individualised patient-care.
AdherePredict was specifically developed with the unique needs of pharmaceutical companies in mind. From launch planning to lifecycle management, it supports your commercial and medical goals by:

Helps patients stay on therapy longer through timely, personalised support.

Reduces failed deliveries, unused stock, and associated costs.

Enhances patient experience and therapy success.

Provides data to support access, reimbursement, and value-based care.
AdherePredict continuously analyses real-world patient data to flag non-adherence risks before they become clinical problems.

Patients engage via digital check-ins, reporting how they feel and any barriers to adherence, providing early indicators of disengagement.

Integrated data from home-care providers and pharmacy delivery logs allows AdherePredict to track whether medicines are being received on time

Smart algorithms score each patient based on clinical history and behavioural risk factors, helping prioritise those who may need extra support.
These are analysed in real-time to:
AdherePredict aligns with NHS goals by helping reduce medicine wastage, prevent avoidable hospitalisations, and enable timely, patient-centred care.
Improves coordination between pharma, delivery partners, nurses, and NHS providers.
Supports patients with tailored education and reminders.
Reduces the burden on NHS services by helping patients stay well at home.
Non-adherence costs pharmaceutical companies billions in lost revenue and reduces the real-world impact of innovative therapies. AdherePredict helps you:
Increase therapy retention rates.
Reduce medicines wastage.
Optimise patient support investments.
Provide clear ROI and health outcome data for payers.
AdherePredict is trusted by leading healthcare partners and pharmaceutical brands. If you're looking for a data-driven, patient-centred approach to adherence, we're here to help.